| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 09/24/2026 | ±3.7% | -2.8% | over-priced |
| 07/17/2026 | ±3.0% | -0.3% | over-priced |
| 03/26/2026 | ±3.7% | +0.3% | over-priced |
| 12/22/2025 | ±2.6% | +2.3% | over-priced |
| 09/30/2025 | ±1.7% | -1.4% | over-priced |
| 07/11/2025 | ±1.4% | -1.4% | over-priced |
| 03/26/2025 | ±1.7% | +4.2% | under-priced |
| 12/19/2024 | ±2.1% | +1.4% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2027 | $1.21 | $1.6B | $430M |
| Q4 FY2026 | — | $1.6B | $421M |
| Q3 FY2026 | $1.56 | $1.8B | $560M |
| Q2 FY2026 | $1.10 | $1.6B | $395M |
Paychex, Inc. Common Stock (PAYX) reports in 55 days, with the next report estimated for 12/22/2026. Across the last 8 reports, options priced an average ±2.5% earnings move while the stock actually moved 1.8% on average — the market has systematically over-priced PAYX's earnings risk. Fundamentals into the print: EPS up 14.2% year-over-year, revenue up 5.9%. QuantLogix's live 5-factor engine currently reads PAYX as a buy at 74/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →